Impact of Metabolic Syndrome on Subclinical Atherosclerosis in Asymptomatic Individuals

Circulation Journal - Japan
doi 10.1253/circj.cj-14-1197
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

Differential Impact of Metabolic Syndrome on Subclinical Atherosclerosis According to the Presence of Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Homocysteine Is Not a Risk Factor for Subclinical Coronary Atherosclerosis in Asymptomatic Individuals

PLoS ONE
Multidisciplinary
2020English

Fatty Liver Largely Explains Associations of Subclinical Hypothyroidism With Insulin Resistance, Metabolic Syndrome, and Subclinical Coronary Atherosclerosis

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2014English

Association of Homocysteine Levels With Subclinical Coronary Atherosclerosis in Asymptomatic Subjects

Laboratory Medicine Online
2016English

Effects of Statin Therapy on Endothelial Function in Asymptomatic Metabolic Syndrome

International Journal of Clinical Medicine
2014English

Metabolic Syndrome, Inflammation and Atherosclerosis

Vascular Health and Risk Management
PharmacologyCardiologyEndocrinologyPublic HealthHematologyEnvironmentalCardiovascular MedicineMedicineOccupational HealthMetabolismDiabetes
2006English

Metabolic Syndrome in Healthy Obese, Overweight, and Normal Weight Individuals: The Atherosclerosis Risk in Communities Study

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2013English

Subclinical Atherosclerosis

2005English

Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis

JAMA - Journal of the American Medical Association
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy